COMPANY

Cyrano Therapeutics

Location: Washington, DC · source · Nov 16, 2020

Profile checked Oct 10, 2026

Keywords: Hyposmia CYR-064

Raises and deals from press releases

Raise Series B · $9M · announced Jan 16, 2024 Company release ↗
Source quote
- Jan 16, 2024 · Company release ↗
  “Cyrano Therapeutics Secures $9.0 Million Series B Financing to Advance Clinical Development of CYR-064 for Treatment of Post-Viral Smell Loss”

Raises announced in these releases: $9M disclosed.

From the company’s own releases; this list is partial. All raises and deals

Jan 16, 2024 Raise Series B · $9M source ↗
Sep 26, 2023 Trial start Phase 2: Study of CYR-064 Versus Placebo in Patients. source ↗

Record	Title	Phase	Status	Start	Primary completion
NCT06019000	Study of CYR-064 Versus Placebo in Patients.	Phase 2	Completed	Sep 26, 2023	Nov 11, 2025 (actual)